CD8A and atrial fibrillation: The frequency of pro-inflammatory CD8+PAR+ T cells (as expressed by positivity for TNF-α and IFN-γ) was higher in AF patients on a non-PAR-directed therapy (ASA/VKA) when compared to the group receiving a PAR-affecting therapy (FXa/FIIa-inhibitor) (Figure 5C).